{"id":"https://openalex.org/W7204100320","doi":"https://doi.org/10.1248/bpb.b26-00201","title":"Impact of Adjusted Creatinine Clearance on Carboplatin Dosing in Endometrial Cancer: A Retrospective Study","display_name":"Impact of Adjusted Creatinine Clearance on Carboplatin Dosing in Endometrial Cancer: A Retrospective Study","publication_year":2026,"publication_date":"2026-08-24","ids":{"openalex":"https://openalex.org/W7204100320","doi":"https://doi.org/10.1248/bpb.b26-00201","pmid":"https://pubmed.ncbi.nlm.nih.gov/42649080"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.b26-00201","doi":"https://doi.org/10.1248/bpb.b26-00201","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b26-00201","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/49/8/49_b26-00201/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/bpb/49/8/49_b26-00201/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036231615","display_name":"Kentaro Katayama","orcid":"https://orcid.org/0000-0002-2859-0423","observed_orcids":["https://orcid.org/0000-0002-2859-0423"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]},{"id":"https://openalex.org/I4210108534","display_name":"Kurashiki Medical Center","ror":"https://ror.org/01kv8e326","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210108534"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kentaro Katayama","raw_affiliation_strings":["Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138530, Japan","Department of Pharmacy, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710\u20138522, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138530, Japan","institution_ids":["https://openalex.org/I163770644"]},{"raw_affiliation_string":"Department of Pharmacy, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710\u20138522, Japan","institution_ids":["https://openalex.org/I4210108534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062072120","display_name":"Makio Imamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108534","display_name":"Kurashiki Medical Center","ror":"https://ror.org/01kv8e326","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210108534"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makio Imamura","raw_affiliation_strings":["Department of Clinical Support, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710\u20138522, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Support, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710\u20138522, Japan","institution_ids":["https://openalex.org/I4210108534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101694648","display_name":"Takashi Uehara","orcid":"https://orcid.org/0000-0002-0688-8827","observed_orcids":["https://orcid.org/0000-0002-0688-8827"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Uehara","raw_affiliation_strings":["Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138530, Japan","institution_ids":["https://openalex.org/I163770644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.59032854,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"49","issue":"8","first_page":"1285","last_page":"1290"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.05570000037550926,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.030500000342726707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carboplatin-dosing","display_name":"carboplatin dosing","score":0.9639999866485596},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cockcroft-gault-equation","display_name":"Cockcroft-Gault formula","score":0.9490000009536743},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9110000133514404},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.6899999976158142},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7649999856948853},{"id":"https://openalex.org/keywords/serum-creatinine-measurement","display_name":"serum creatinine measurement","score":0.7110000252723694},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.6859999895095825},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9070000052452087},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8458999991416931},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6869999766349792},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6635000109672546},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.4959999918937683},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4575999975204468},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.438400000333786},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.39239999651908875},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3831999897956848},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3346000015735626},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3089999854564667},{"id":"https://openalex.org/C138944611","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Clearance","level":2,"score":0.27889999747276306},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25699999928474426}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1248/bpb.b26-00201","doi":"https://doi.org/10.1248/bpb.b26-00201","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b26-00201","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/49/8/49_b26-00201/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:42649080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42649080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01081:0007532548","doi":null,"is_oa":true,"landing_page_url":"https://ousar.lib.okayama-u.ac.jp/71239","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal article"},{"id":"pmh:oai:EPrintsOUDIR.lib.okayama-u.ac.jp:71239","doi":null,"is_oa":true,"landing_page_url":"https://ousar.lib.okayama-u.ac.jp/71239","pdf_url":"https://ousar.lib.okayama-u.ac.jp/files/public/7/71239/20260924164354509966/fulltext.pdf","source":{"id":"https://openalex.org/S4377196325","display_name":"Okayama University Scientific Achievement Repository (Okayama University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I163770644","host_organization_name":"Okayama University","host_organization_lineage":["https://openalex.org/I163770644"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.b26-00201","doi":"https://doi.org/10.1248/bpb.b26-00201","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b26-00201","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/49/8/49_b26-00201/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1558097412","display_name":null,"funder_award_id":"JPJS00420230010","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G3675246249","display_name":"Integrated understanding of the mechanisms of maintenance and breakdown of epigenomic resilience for health","funder_award_id":"24H00678","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G3895714700","display_name":null,"funder_award_id":"24H00678","funder_id":"https://openalex.org/F4320320912","funder_display_name":"Ministry of Education, Culture, Sports, Science and Technology"}],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204100320.pdf","grobid_xml":"https://content.openalex.org/works/W7204100320.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408922136","https://openalex.org/W2144756579","https://openalex.org/W2082976272","https://openalex.org/W3136317918","https://openalex.org/W230435023","https://openalex.org/W2418832612","https://openalex.org/W1733542310","https://openalex.org/W2119107859","https://openalex.org/W2313543906","https://openalex.org/W2896370738"],"abstract_inverted_index":{"Carboplatin":[0],"(CBDCA)":[1],"dosing":[2,71,153,165],"is":[3,25],"commonly":[4],"determined":[5],"using":[6],"the":[7,16,75,104,109,122,127,138,141,148,176,183],"Calvert":[8],"formula,":[9],"with":[10,54],"creatinine":[11,23],"clearance":[12],"(Ccr)":[13],"estimated":[14],"by":[15,86],"Cockcroft-Gault":[17,77],"formula.":[18],"In":[19],"Japan,":[20],"where":[21],"serum":[22],"(sCr)":[24],"usually":[26],"measured":[27],"enzymatically,":[28],"unadjusted":[29],"Ccr":[30,84],"may":[31,166],"overestimate":[32],"glomerular":[33],"filtration":[34],"rate":[35,117],"and":[36,48,182],"lead":[37],"to":[38,68,90,193],"CBDCA":[39,62,70],"overdosing.":[40],"We":[41],"retrospectively":[42],"compared":[43],"treatment":[44],"exposure,":[45],"hematologic":[46,168],"toxicity,":[47],"exploratory":[49],"oncologic":[50,155,198],"outcomes":[51,156],"in":[52,103,108,121,126,170,186],"patients":[53],"endometrial":[55],"cancer":[56],"who":[57],"received":[58],"postoperative":[59],"paclitaxel":[60],"plus":[61],"therapy.":[63],"Patients":[64],"were":[65],"grouped":[66],"according":[67],"whether":[69],"was":[72,100,118,135,146],"based":[73],"on":[74,82,154,197],"conventional":[76],"formula":[78],"(CG":[79],"group)":[80],"or":[81],"adjusted":[83,105,123,151,163],"calculated":[85],"adding":[87],"0.2":[88],"mg/dL":[89],"sCr":[91],"(adjusted":[92],"group).":[93],"The":[94,112],"incidence":[95],"of":[96,143,150,179],"Grade":[97],"\u22653":[98],"neutropenia":[99],"significantly":[101],"lower":[102,120],"group":[106,124],"than":[107,125],"CG":[110,128],"group.":[111],"5-year":[113],"progression-free":[114],"survival":[115,187],"(PFS)":[116],"numerically":[119],"group,":[129],"although":[130],"no":[131],"statistically":[132],"significant":[133],"difference":[134],"observed":[136],"between":[137],"groups.":[139],"Because":[140],"number":[142,178],"PFS":[144,180],"events":[145,181],"limited,":[147],"effect":[149],"Ccr-based":[152,164],"remains":[157],"uncertain.":[158],"These":[159],"findings":[160],"suggest":[161],"that":[162],"reduce":[167],"toxicity":[169],"routine":[171],"clinical":[172],"practice.":[173],"However,":[174],"given":[175],"limited":[177],"wide":[184],"uncertainty":[185],"estimates,":[188],"further":[189],"studies":[190],"are":[191],"needed":[192],"clarify":[194],"its":[195],"impact":[196],"outcomes.":[199]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-08-25T00:00:00"}